Answers are grounded in this paper and cite their sources.
To understand the evolutionary characteristics of HIV-1 variants resistant to protease inhibitors (PI), the replicating plasma virus was analyzed in three patients shifted to PI-sparing regimen after virological failure. The dynamic features of carryover mutations associated with PI resistance in the absence of selective pressure on the protease gene indicate that viral variants resistant to reverse transcriptase inhibitors and bearing mutations of the protease sequence can maintain efficient replication capacity in vivo.
No takes yet. Share an insight, caveat, or question.
Boeri et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: